Specialty Renal Products Inc.
Medical device company focused on the development of products for patients with renal disease
Medical device company focused on the development of products for patients with renal disease
Specialty Renal Products Inc. is a healthcare startup focused on developing products for patients with renal disease. As a subsidiary of Nephros, Inc., the company is dedicated to creating innovative solutions to improve the treatment of End Stage Renal Disease (ESRD) patients. Their flagship product, a hemodiafiltration (HDF) system, has garnered attention in the industry.
The company's recent $3.00M Series A investment in September 2018, led by Wexford Capital and Arbor Capital, signifies a growing interest in their disruptive technologies. This investment bolsters their position in the market and acknowledges their potential in addressing the unmet needs of renal disease patients.
Specialty Renal Products Inc.'s commitment to pioneering advancements in the healthcare space and their strategic partnerships with notable investors position them as a compelling player in the renal care industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $3.00M | 2 | Wexford Capital, Arbor Capital | 06 Sep 2018 |
No recent news or press coverage available for Specialty Renal Products Inc..
We care about your data, and we'd love to use cookies make your experience better.
